PCRI's Alex asks medical oncologist Mark Scholz, questions that were asked by viewers of our 2022 Mid-Year Prostate Cancer Conference on the topics of radiotherapy, PSMA PET scans, metastatic disease, and Provenge.

To view day one of our conference, visit:    • Active Surveillance, Incontinence & E...  
To view day 2, visit:    • Radiation, Advanced Treatments,  Side...  

0:25 Does radiation for a different cancer preclude being able to receive radiotherapy for prostate cancer?

3:46 How do you know if you're radio-resistant after treatment?

5:58 Would getting a PSMA scan after radiation be advisable?

6:47 How often do PSMA PET scans show false positives?

8:30 How often does PSMA PET scan fail to detect metastases when they exist?

9:25 How should you monitor yourself after a clear PSMA PET scan to be sure sure that you are not one of the 10% of people whose cancers do no produce PSMA?

9:51 Do you differentiate between regional lymph node metastases and oligometastases?

11:10 If Provenge effective in men with metastatic castrate-sensitive disease?

12:12 Why isn't Provenge being studied in metastatic castrate-sensitive disease?

Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org

To learn more about prostate cancer visit http://www.pcri.org

Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join

Sign up for our newsletter here: https://pcri.org/#join-our-newsletter

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

#ProstateCancer #Prostate #MarkScholzMD